OpenAI has acquired Orchestra Bio, a platform that uses AI agents to manage drug development workflows. The company launched in 2025 with about $20 million in funding from investors including Andreessen Horowitz. OpenAI plans to combine Orchestra with its Rosalind platform to shorten the typical 10 to 15 year drug development timeline. The company already partners with Novo Nordisk and Moderna on related efforts.
Key Takeaways
- <ul><li>OpenAI acquired Orchestra Bio to apply AI agents to drug development, targeting a reduction in the 10 to 15 year timeline</li><li>Orchestra Bio launched in 2025 with roughly $20 million in funding from Andreessen Horowitz</li><li>Meta's Muse AI agent hit 10.9 million total downloads and 2.5 million US downloads in 40 days</li><li>CoreWeave holds $103.7 billion in customer contracts with 40 percent due in 2028, counting Microsoft, OpenAI, and likely Nvidia among major clients</li><li>Forbes joined Google's paid News AI pilot, which now includes over 400 publications</li><li>SAP introduced AI-powered roleplays for more than 100 certifications in its Stay Certified program</li><li>IREN projects revenues of US$13.6 billion and earnings of US$1.6 billion by 2029</li><li>The GAO outlined a 2027 to 2032 plan to monitor federal AI use and hire AI experts</li></ul>
OpenAI buys Orchestra Bio to speed up drug development
OpenAI acquired Orchestra Bio to combine its coordination platform with Rosalind. The goal is to shorten the 10 to 15 year drug development timeline using AI agents. These agents help manage studies, track problems, and present options for leaders. GPT-Rosalind is limited to approved users under a trusted-access program. OpenAI did not share the purchase price or integration timeline.
OpenAI acquires Orchestra Bio for drug discovery
OpenAI acquired Orchestra Bio, a platform that uses AI agents to track drug development workflows. The company was founded in San Francisco by CEO Ashoka Rajendra and CTO Andy Xu. It launched in 2025 with about $20 million in funding from investors including Andreessen Horowitz. OpenAI wants to combine Orchestra with Rosalind to manage the full drug discovery process. OpenAI already partners with Novo Nordisk and Moderna.
OpenAI acquires Orchestra Bio for life sciences R&D
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences research. Developing a new medicine takes roughly 10 to 15 years from target discovery to US regulatory approval. Orchestra's platform uses AI agents to monitor studies and flag problems that could cause delays. The plan is to combine Orchestra with Rosalind to help teams connect scientific findings with next steps. OpenAI aims to help new medicines reach patients sooner.
Meta's Muse AI agent reaches 10.9 million downloads
Meta's Muse AI agent reached 10.9 million downloads while ChatGPT saw a 25% decline. Sensor Tower reported Muse hit 2.5 million US downloads. Only 11 other apps have reached 10 million US downloads within 40 days. Deutsche Bank analyst Benjamin Black said Muse fills a unique space combining mobile access, autonomous transactions, and a free-to-use model. Meta is investing heavily in promoting the app.
Meta's Muse hits 10 million US downloads in 40 days
Meta's Muse reached 10 million US downloads in 40 days, a milestone achieved by only 11 other apps. Meta's Threads was the last app to reach this mark in July 2023. Meta allocated 39% of its advertising spend to market Muse in October. Muse has a 30% retention rate after 7 days, outperforming rivals like ChatGPT and Claude. Its daily active users reached 2.5 million on October 16.
CoreWeave's heavy debt worries the AI industry
CoreWeave's bond values dropped, raising concerns across the AI sector. The company wants investment-grade debt so it can borrow from insurers. CoreWeave holds $103.7 billion in customer contracts, with 40 percent due in 2028. Major customers include Microsoft, OpenAI, and likely Nvidia. Other AI companies like Oracle also feel the pressure.
Forbes joins Google's paid AI news pilot program
Forbes joined Google's paid News AI pilot to test new ways of presenting stories before readers click through. The program pays publishers for Google's use of enhanced content and features article overviews with attribution and links. Forbes reported a 45 percent drop in referrals year over year. Google launched the program last December and now has over 400 participating publications.
OtterlyAI and Profound differ in AI search tracking approach
OtterlyAI and Profound both track how brands appear in AI search answers but use different sales models. OtterlyAI is self-serve with plans from $29 to $489 per month and a free trial. Profound is sales-led with a custom Enterprise plan and a seven-day free trial. Both tools track daily, read server logs, and support engines like ChatGPT, Perplexity, and Google AI Overviews.
SAP adds AI roleplays to certification renewal process
SAP introduced AI-powered roleplays for its Stay Certified program starting in October. Certified professionals can now complete short practical assessments based on real-world customer scenarios instead of only written exams. The roleplays cover more than 100 certifications and provide personalized feedback after each assessment. Learners who prefer non-AI options can still take stand-alone assessment quizzes.
AI predicts Lamine Yamal leads 2026 Ballon d'Or race
AI company Avisia predicted Lamine Yamal has a 23 percent chance of winning the 2026 Ballon d'Or. Harry Kane follows at 21 percent, Kylian Mbappe at 19 percent, Rodri at 19 percent, and Lionel Messi at 18 percent. The model uses performance data, media coverage, and past voting patterns. Avisia correctly predicted the 2025 winner and claims 75 percent accuracy for the 2026 World Cup.
How to measure the real return on AI marketing investments
AI marketing ROI measures the financial and operational gains from using AI in marketing compared to its total costs. Costs include software, integration, training, and employee time, while returns can be extra profit, time saved, or lower content costs. Measuring ROI is difficult because it is hard to separate AI's impact from other factors like new campaigns or seasonal demand. A clear baseline before using AI is needed for reliable comparison. In 2025, most businesses saw returns only after one to two years, and just 6 percent saw returns in less than 12 months.
IREN's debt free AI data centers may reshape its investment story
IREN is a neocloud operator expanding AI data centers in Texas and Canada with a debt free balance sheet. Customer prepayments cover 45 to 55 percent of GPU costs, and contracts run for three years. Management reports capacity substantially contracted into 2026 and 2027. The key question is whether IREN can fill new capacity with durable AI contracts while keeping build costs and energy inputs under control. Analysts forecast revenues of US$13.6 billion and earnings of US$1.6 billion by 2029, though that assumes 168 percent yearly revenue growth.
GAO plans to watch government AI use and hire AI experts
The GAO outlined its 2027 to 2032 plan to help Congress track emerging technology trends, especially artificial intelligence. It will monitor federal AI efforts, assess national security risks, and evaluate AI policy and regulatory frameworks. The office also plans to hire experts in data science, AI, and cybersecurity while modernizing its own IT systems. Acting Comptroller General Orice Williams Brown said agencies must adapt quickly as technology reshapes jobs and government work.
Sources
- OpenAI buys Orchestra Bio to cut drug timelines
- OpenAI Acquires AI-Powered Drug Development Platform Orchestra Bio
- OpenAI acquires Orchestra Bio
- Meta's Muse AI agent hits 10.9 million downloads as ChatGPT slides 25%
- Meta's Muse hits 10M U.S. downloads in 40 days, a milestone reached by only 11 other apps
- CoreWeave’s debt is becoming the whole AI industry’s problem
- Forbes looks to Google AI pilot for insights as publishers seek value beyond the click
- Self-Serve or Sales-Led: What Separates OtterlyAI From Profound in AI Search Tracking
- SAP Introduces AI-Powered Roleplays to Help Learners Stay Certified
- His prediction was correct in 2025: artificial intelligence picks its candidate for the Ballon d'Or
- AI marketing ROI: What your AI investment actually returns
- Did Debt Free AI Capacity Just Shift IREN Stock's Investment Narrative?
- GAO to monitor government AI use, hire AI experts in coming years
Comments
Please log in to post a comment.